Vistin Pharma ASA (OSL: VISTN)
Norway
· Delayed Price · Currency is NOK
23.40
-0.30 (-1.27%)
Jan 3, 2025, 9:00 AM CET
Vistin Pharma ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 5.63 | 26.2 | 1.44 | 35.75 | 77.04 | 319.67 | Upgrade
|
Cash & Short-Term Investments | 5.63 | 26.2 | 1.44 | 35.75 | 77.04 | 319.67 | Upgrade
|
Cash Growth | 133.07% | 1726.06% | -95.99% | -53.60% | -75.90% | -0.33% | Upgrade
|
Accounts Receivable | 61.28 | 47.02 | 66.16 | 40.25 | 30.4 | 38.28 | Upgrade
|
Other Receivables | 4.48 | 12.56 | 5.01 | 2.85 | 1.45 | 10.65 | Upgrade
|
Receivables | 65.76 | 59.59 | 71.17 | 43.09 | 31.85 | 48.93 | Upgrade
|
Inventory | 72.43 | 80.17 | 83.45 | 42.91 | 31.79 | 24.11 | Upgrade
|
Prepaid Expenses | - | 2.81 | 3.14 | 16.09 | 0.85 | 1.92 | Upgrade
|
Total Current Assets | 143.82 | 168.77 | 159.18 | 137.83 | 141.53 | 394.63 | Upgrade
|
Property, Plant & Equipment | 230.29 | 219.98 | 219.43 | 167.46 | 145.26 | 101.8 | Upgrade
|
Long-Term Deferred Tax Assets | 2.4 | 14.64 | 28.6 | 27.86 | 35.13 | 7.73 | Upgrade
|
Other Long-Term Assets | 11.43 | - | - | 0 | - | 0 | Upgrade
|
Total Assets | 387.94 | 403.4 | 407.21 | 333.15 | 321.92 | 504.17 | Upgrade
|
Accounts Payable | 18.3 | 18.92 | 25.91 | 20.81 | 17.89 | 23.61 | Upgrade
|
Accrued Expenses | - | 16.6 | 14.67 | 16.58 | 11.69 | 10.25 | Upgrade
|
Short-Term Debt | 5.64 | - | 45.14 | - | - | - | Upgrade
|
Current Portion of Leases | 0.96 | 1 | 1.07 | 0.88 | - | 1.3 | Upgrade
|
Current Income Taxes Payable | - | - | - | - | - | 3.8 | Upgrade
|
Other Current Liabilities | 42.5 | 32.95 | 30.78 | 2.78 | 2.62 | 34.29 | Upgrade
|
Total Current Liabilities | 67.4 | 69.47 | 117.57 | 41.04 | 32.2 | 73.24 | Upgrade
|
Long-Term Leases | 1.54 | 2.29 | 2.96 | 0.51 | - | 1.22 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | -0 | 0 | 0.98 | - | Upgrade
|
Total Liabilities | 77.21 | 80.63 | 133.73 | 57.38 | 49.51 | 90.77 | Upgrade
|
Common Stock | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 | Upgrade
|
Additional Paid-In Capital | 151.47 | 206.89 | 206.89 | 206.89 | 229.06 | 273.4 | Upgrade
|
Retained Earnings | 114.92 | 71.54 | 22.26 | 24.54 | -1 | 95.65 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | - | 0 | Upgrade
|
Shareholders' Equity | 310.74 | 322.77 | 273.49 | 275.77 | 272.41 | 413.4 | Upgrade
|
Total Liabilities & Equity | 387.94 | 403.4 | 407.21 | 333.15 | 321.92 | 504.17 | Upgrade
|
Total Debt | 8.14 | 3.29 | 49.17 | 1.39 | - | 2.52 | Upgrade
|
Net Cash (Debt) | -2.51 | 22.91 | -47.73 | 34.36 | 77.04 | 317.15 | Upgrade
|
Net Cash Growth | - | - | - | -55.40% | -75.71% | -1.12% | Upgrade
|
Net Cash Per Share | -0.06 | 0.52 | -1.08 | 0.77 | 1.74 | 7.15 | Upgrade
|
Filing Date Shares Outstanding | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | Upgrade
|
Total Common Shares Outstanding | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | Upgrade
|
Working Capital | 76.43 | 99.3 | 41.61 | 96.8 | 109.32 | 321.39 | Upgrade
|
Book Value Per Share | 7.01 | 7.28 | 6.17 | 6.22 | 6.14 | 9.32 | Upgrade
|
Tangible Book Value | 310.74 | 322.77 | 273.49 | 275.77 | 272.41 | 413.4 | Upgrade
|
Tangible Book Value Per Share | 7.01 | 7.28 | 6.17 | 6.22 | 6.14 | 9.32 | Upgrade
|
Machinery | - | 263.53 | 253.37 | - | 87.23 | 41.78 | Upgrade
|
Construction In Progress | - | 17.91 | 10.24 | - | 56.56 | 50.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.